A VAB Venture
Home
About Us
About Us
Vision
Mission
COMPANY AFFAIRS
Financial Results
2018-2019
2017-2018
2016-2017
2015-2016
Annual Reports
2018-19
Annexure MGT -9 (2017-18)
2017-2018
2016-2017
2015-2016
2014-2015
Annual General Meeting
Ballot Paper 15-16
Quarterly Results
June 2019
December 2018
QE 300618
December 2017
June 2016
Company Reports
Investors' Relations
Company Policies
Code of Conduct for the Board and Senior Management
Insider Trading Policy
Amended Insider Trading Policy
Policy for determination of Materiality
Policy on Preservation of Documents and Archival
Policy on Related Party Transactions
Whistle Blower Policy
Board of Directors & Committees
Directors
Notices
AGM 2018-19 Notice
OCBM Notice
Corporate Announcements
Shareholding Pattern
2019
March
2018
December
September
June
March
Corporate Governance
Details of Registrar and Transfer Agent(RTA)
Evoting Reports
Auditors
Business
International Business
Business Model
Marketing Overview
Products
APIs
Guaifenesin USP/EP/BP/IP
Methocarbamol USP
Phenazopyridine Hcl
Fluconazole USP/EP
Melitracen Hcl
Metformin Hcl
Ambroxol Hcl BP/IP
Forthcoming APIs
Flupentixol DIHCL BP
Domperidone BP/EP
Mephenesin BP
Mefanemic Acid USP/BP/IP
Chlorophenesin USP/BP
Brochure
Gennex Brochure
Gennex Products in Pipeline
Gallery
Facility
Quality
Certifications
IMS Policy English
IMS Policy Telugu
Careers
Contact Us
IMS Policy